MedCity Influencers

BioCrossroads announces New Venture Competition for life sciences companies

This post is sponsored by BioCrossroads. At a press conference today announcing the Indiana Seed Fund II (ISFII), BioCrossroads also launched the inaugural BioCrossroads New Venture Competition presented by Krieg DeVault, an early stage business competition open to life sciences (biotechnology, pharmaceutical, medical device, diagnostic, ag-biotech) and health information technology companies holding a substantial nexus […]

This post is sponsored by BioCrossroads.

At a press conference today announcing the Indiana Seed Fund II (ISFII), BioCrossroads also launched the inaugural BioCrossroads New Venture Competition presented by Krieg DeVault, an early stage business competition open to life sciences (biotechnology, pharmaceutical, medical device, diagnostic, ag-biotech) and health information technology companies holding a substantial nexus to Indiana and a high potential for attracting investment capital.

In addition to a cash prize of $25,000, the winner of the competition will have access to the Indiana Seed Fund II staff and the fund’s network of resources to provide business planning and early-stage strategic support.  They will also have the opportunity to make a presentation to the ILSFII investment committee.

Sponsored Post

Physician Targeting Using Real-time Data: How PurpleLab’s Alerts Can Help

By leveraging real-time data that offers unprecedented insights into physician behavior and patient outcomes, companies can gain a competitive advantage with prescribers. PurpleLab®, a healthcare analytics platform with one of the largest medical and pharmaceutical claims databases in the United States, recently announced the launch of Alerts which translates complex information into actionable insights, empowering companies to identify the right physicians to target, determine the most effective marketing strategies and ultimately improve patient care.

The winner will be announced at the Indiana Life Sciences Summit Networking Reception on October 22, 2012.  Second and third place companies will be awarded cash prizes of $15,000 and $10,000 respectively.  There will also be a Pre-Venture prize of $10,000 for a promising technology that is very early in its development.

The competition will be comprised of an initial application process followed by ISFII staff review of all applications, interviews of semi-finalists and the selection and invitation of the top five plans to present to a panel of expert judges.  Applications are available at www.biocrossroads.com and must be submitted by Tuesday, July 31, 2012.   Companies invited to submit full business plans must do so by Friday, August 24, 2012.

Early-stage biotechnology, pharmaceutical, medical device, diagnostic, ag-biotech or health information technology companies developing innovative products and platforms are eligible to apply for the New Venture Competition.  For consideration, companies must either be Indiana-based or be able to demonstrate a significant Indiana presence.

CHV Capital, Inc., Credit Suisse, Indiana Health Information Exchange, and StepStone Business Partners are sponsors of BioCrossroads New Venture Competition presented by Krieg DeVault.

BioCrossroads is Indiana's initiative to grow, advance and invest in the life sciences, a public-private collaboration that supports the region's existing research and corporate strengths while encouraging new business development.

This post appears through the MedCity Influencers program. Anyone can publish their perspective on business and innovation in healthcare on MedCity News through MedCity Influencers. Click here to find out how.

Topics